Search

Search Constraints

You searched for: Author/Creator Ang, Celina

Search Results

21. KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases. Issue 24 (25th August 2014)

25. Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC. Issue 7 (28th April 2022)

26. Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study. Issue 2 (31st August 2020)

28. Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study. Issue 4 (8th April 2022)

29. Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study. (13th January 2023)

30. Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study. (November 2022)